Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Vivian Scheuplein"'
Autor:
Josefine Krüger, Matthias Obenaus, Igor Wolfgang Blau, Dana Hoser, Martin Vaegler, Hana Rauschenbach, Ioannis Anagnostopoulos, Korinna Jöhrens, Vivian Scheuplein, Elisa Kieback, Judith Böhme, Ann-Christin von Brünneck, Jan Krönke, Antonia Busse, Gerald Willimsky, Thomas Blankenstein, Antonio Pezzutto, Ulrich Keller, Axel Nogai
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/c30a3e990da440aeb648d5ee283c6126
Autor:
Lena Immisch, George Papafotiou, Nerea Gallarín Delgado, Vivian Scheuplein, Annette Paschen, Thomas Blankenstein, Gerald Willimsky
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Recurrent neoepitopes are cancer-specific antigens common among groups of patients and therefore ideal targets for adoptive T cell therapy. The neoepitope FSGEYIPTV carries the Rac1P29S amino acid change caused by a c.85C>T missense mutation, which i
Externí odkaz:
https://doaj.org/article/ed394da54e544d6e923619bf5e6c2076
Autor:
Ronald Simon, Thomas Blankenstein, Jennifer Oduro, Natalia Gorbokon, Christoph Fraune, Julia Bluhm, Vivian Scheuplein, Elisa Kieback, Matthias Obenaus, Eugen Leo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/ba13c44bf5c24d86a2ab8e2c4ce320de
Autor:
Matthias Leisegang, Thomas Blankenstein, Vivian Scheuplein, Elisa Kieback, Matthias Obenaus, Ioannis Gavvovidis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/5764ca011aa54c308996bdffb02e1ba6
Autor:
Fiona Thistlethwaite, Sylvie Rottey, Emiliano Calvo, Antonia Busse, Martin Wermke, Ralf Wolter, Thomas Blankenstein, Vivian Scheuplein, Elisa Kieback, Matthias Obenaus, Eugen Leo, Ioannis Gavvovidis, Marie-Luise Goebeler, Nuria Kotecki, Carolina Perdomo-Ortiz
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/795cb33ed4024620a0e2bdd6fb8742d4
Autor:
Gerald Willimsky, Christin Beier, Lena Immisch, George Papafotiou, Vivian Scheuplein, Andrean Goede, Hermann-Georg Holzhütter, Thomas Blankenstein, Peter M Kloetzel
Publikováno v:
eLife, Vol 10 (2021)
Proteasome-catalyzed peptide splicing (PCPS) of cancer-driving antigens could generate attractive neoepitopes to be targeted by T cell receptor (TCR)-based adoptive T cell therapy. Based on a spliced peptide prediction algorithm, TCRs were generated
Externí odkaz:
https://doaj.org/article/9f5ae7c804744ee4a8d414cf5560bcb4
Autor:
Emiliano Calvo, Antonia Busse, Martin Wermke, Fiona C Thistlethwaite, Ralf Wolter, Sylvie Rottey, Matthias Obenaus, Ioannis Gavvovidis, Marie-Luise Goebeler, Vivian Scheuplein, Elisa Kieback, Eugen Leo, Nuria Kotecki, Carolina Perdomo-Ortiz, Thomas Blankenstein
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundMelanoma-associated antigen 1 (MAGE-A1) is a cancer-testis antigen with highly selective expression in testis (which is an immune privileged site) and in multiple high unmet medical need cancers. Therefore, it represents an attractive targe
Autor:
Vivian Scheuplein, Andrean Goede, Peter M. Kloetzel, Thomas Blankenstein, George Papafotiou, Hermann-Georg Holzhütter, Gerald Willimsky, Lena Immisch, Christin Beier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4372e6db292809ac8ca90c40b436e7d3
https://doi.org/10.7554/elife.62019.sa2
https://doi.org/10.7554/elife.62019.sa2
Autor:
Christin Beier, Lena Immisch, Peter M. Kloetzel, Thomas Blankenstein, Vivian Scheuplein, Andrean Goede, Georgios Papafotiou, Hermann-Georg Holzhütter, Gerald Willimsky
Publikováno v:
eLife, Vol 10 (2021)
eLife
eLife
Proteasome-catalyzed peptide splicing (PCPS) of cancer-driving antigens could generate attractive neoepitopes to be targeted by T cell receptor (TCR)-based adoptive T cell therapy. Based on a spliced peptide prediction algorithm, TCRs were generated
Autor:
Lena Immisch, George Papafotiou, Nerea Gallarín Delgado, Vivian Scheuplein, Annette Paschen, Thomas Blankenstein, Gerald Willimsky
Publikováno v:
Frontiers in Immunology. 14
Recurrent neoepitopes are cancer-specific antigens common among groups of patients and therefore ideal targets for adoptive T cell therapy. The neoepitope FSGEYIPTV carries the Rac1P29S amino acid change caused by a c.85C>T missense mutation, which i